Physician

Alexandra Fingesten, MD

According to 2025 Medicare claims, Alexandra Fingesten, MD (NPI: 1972658185) practices geriatric medicine in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. Fingesten uses personal NPI as billing NPI and primary practice location at 10016-6055. Fingesten is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Fingesten's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 312 traditional Medicare patients, billed 2,294 HCPCS/CPT codes, and received $150,743 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,213 prescription claims across 371 beneficiaries totaling $1,014,694 in drug costs, led by Ozempic (Semaglutide). DME data shows 42 claims. Open Payments data shows 98 records totaling $1,792. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $58,495 to $150,743. Similarly, Part D prescription costs have risen steadily, from $415,007 to $1,014,694. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,193 and ending at $9,113.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	180	1,573	$58,495
2016	197	1,660	$66,972
2017	232	1,751	$71,327
2018	244	1,705	$70,922
2019	268	1,715	$76,757
2020	279	1,779	$81,598
2021	310	2,132	$115,830
2022	328	2,324	$129,301
2023	327	2,461	$146,390
2024	312	2,294	$150,743

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	203	4,112	$415,007
2016	218	4,632	$481,067
2017	239	5,598	$568,469
2018	270	5,684	$575,163
2019	285	6,071	$690,728
2020	305	6,069	$702,394
2021	344	6,384	$772,726
2022	373	6,311	$747,942
2023	363	6,524	$892,378
2024	371	7,213	$1,014,694

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	55	$1,372
2016	N/R	N/R	N/R
2017	N/R	16	$609
2018	N/R	48	$958
2019	N/R	31	$1,067
2020	N/R	19	$178
2021	N/R	13	$126
2022	N/R	29	$1,626
2023	N/R	28	$3,290
2024	N/R	42	$1,486

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	200	200	$156
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	279	643	$108
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	189	463	$66
36415	Insertion of needle into vein for collection of blood sample	298	564	$9
81002	Urinalysis, manual test	98	112	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	65	2,872	$85,888
Mounjaro	Tirzepatide	51	1,786	$64,098
Eliquis	Apixaban	75	3,150	$63,291
Xarelto	Rivaroxaban	58	2,850	$52,672
Vraylar	Cariprazine Hcl	31	930	$43,184

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1811	Static progressive stretch knee device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories	Y	N/R	12	$1,168
K0001	Standard wheelchair	Y	N/R	18	$238
K0195	Elevating leg rests, pair (for use with capped rental wheelchair base)	Y	N/R	12	$80

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	98	$1,792	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

Geriatric medicine providers in the New York-Jersey City-White Plains, NY-NJ market
Providers within practice ZIP code 10016-6055
Providers whose plurality patient county is New York, NY
Providers in New York affiliated with CoreHealth Alliance LLC (MSSP)

FAQ

What Medicare data is available for Alexandra Fingesten, MD?

Tedicare shows public-source Medicare data for Alexandra Fingesten, MD (NPI 1972658185), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra Fingesten, MD have ACO affiliation data?

Alexandra Fingesten, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Alexandra Fingesten, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Alexandra Fingesten, MD have Open Payments data?

Alexandra Fingesten, MD has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.